Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.48 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.48 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.47 |
| ▸ | SELE | P16581 | 1/20 | 0.47 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | CCNC | P24863 | 1/20 | 0.41 |
| ▸ | CDK8 | P49336 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.40 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.40 |
| ▸ | GSK3A | P49840 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15142261 | 0.76 | CSNK2A2 (0.50) | CSNK2A2CSNK2BCSNK2A1KDRICAM1 | |
| SCHEMBL19439584 | 0.76 | PTPN2 (0.49) | CSNK2A2CSNK2BCSNK2A1KDRICAM1 | |
| SCHEMBL828902 | 0.73 | CSNK2A2 (0.48) | CSNK2A2CSNK2BCSNK2A1KDRICAM1 | |
| SCHEMBL18610722 | 0.72 | CSNK2A2 (0.47) | CSNK2A2CSNK2BCSNK2A1KDRICAM1 | |
| SCHEMBL829703 | 0.72 | CSNK2A2 (0.47) | CSNK2A2CSNK2BCSNK2A1KDRICAM1 | |
| SCHEMBL806489 | 0.72 | SLC9A1 (0.58) | CSNK2A2CSNK2BCSNK2A1KDRICAM1 | |
| SCHEMBL829477 | 0.71 | CCNC (0.48) | CSNK2A2CSNK2BCSNK2A1KDRICAM1 | |
| SCHEMBL829006 | 0.71 | CSNK2A2 (0.46) | CSNK2A2CSNK2BCSNK2A1KDRICAM1 | |
| SCHEMBL9925990 | 0.71 | KDM4E (0.67) | CSNK2A2CSNK2BCSNK2A1KDRHPGD | |
| SCHEMBL828767 | 0.70 | CSNK2A2 (0.44) | CSNK2A2CSNK2BCSNK2A1KDRICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10403833-B2 | Organic metal complexes | MERCK PATENT GMBH (DE) | 2019-09-03 | — | — | US | disclosed |
| EP-2856528-B1 | METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS | MERCK PATENT GMBH (DE) | 2019-07-03 | — | — | EP | disclosed |
| US-9879177-B2 | Metal complexes comprising condensed heteroaromatic rings | MERCK PATENT GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| US-9879177-B2 | Metal complexes comprising condensed heteroaromatic rings | MERCK PATENT GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| US-20170317298-A1 | ORGANIC METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2017-11-02 | — | — | US | disclosed |
| US-20170317298-A1 | ORGANIC METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2017-11-02 | — | — | US | disclosed |
| US-9748502-B2 | Organic metal complexes | MERCK PATENT GMBH (DE) | 2017-08-29 | — | — | US | disclosed |
| US-9748502-B2 | Organic metal complexes | MERCK PATENT GMBH (DE) | 2017-08-29 | — | — | US | disclosed |
| EP-2791275-B1 | ORGANIC SENSITIZERS FOR UP-CONVERSION | MERCK PATENT GMBH (DE) | 2017-05-31 | — | — | EP | disclosed |
| EP-2797940-B1 | METAL COMPLEXES COMPRISING 1,2,3-TRIAZOLES | MERCK PATENT GMBH (DE) | 2016-02-24 | — | — | EP | disclosed |
| US-20140371825-A1 | ORGANIC METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2014-12-18 | — | — | US | disclosed |
| US-20140371825-A1 | ORGANIC METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2014-12-18 | — | — | US | disclosed |
| US-20140358198-A1 | ORGANIC SENSITIZERS FOR UP-CONVERSION | MERCK PATENT GMBH (DE) | 2014-12-04 | — | — | US | disclosed |
| US-20140358198-A1 | ORGANIC SENSITIZERS FOR UP-CONVERSION | MERCK PATENT GMBH (DE) | 2014-12-04 | — | — | US | disclosed |
| US-20140350642-A1 | Metal Complexes Comprising 1,2,3-Triazoles | MERCK PATENT GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| US-20140350642-A1 | Metal Complexes Comprising 1,2,3-Triazoles | MERCK PATENT GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| WO-2013174471-A1 | METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS | MERCK PATENT GMBH (DE) | 2013-11-28 | — | — | WO | disclosed |
| WO-2013107487-A1 | ORGANIC METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2013-07-25 | — | — | WO | disclosed |
| WO-2013097920-A1 | METAL COMPLEXES COMPRISING 1,2,3-TRIAZOLES | MERCK PATENT GMBH (DE) | 2013-07-04 | — | — | WO | disclosed |
| WO-2013087162-A1 | ORGANIC SENSITIZERS FOR UP-CONVERSION | MERCK PATENT GMBH (DE) | 2013-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10403833-B2 | Organic metal complexes | SOD1, ORC3, PPIA | CSNK2A2 3589/4885CSNK2B 3673/4885CSNK2A1 3733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.